Vol 2, No 3 (July 08, 2013): Annals of Palliative Medicine

Editorial

Usage of EGFR-TKI and WBRT in NSCLC patients with brain metastases
Yuh-Min Chen
Annals of Palliative Medicine  
2013;
2
(3)
:108-110
.
Efficacy of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small cell lung cancer
Tomonobu Koizumi, Shigeru Sasaki, Akiyuki Sakamoto, Takashi Kobayashi
Annals of Palliative Medicine  
2013;
2
(3)
:111-113
.
Treatment of brain metastases in non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations: the role of EGFR tyrosine kinase inhibitors
Niki Karachaliou, Rafael Rosell
Annals of Palliative Medicine  
2013;
2
(3)
:114-117
.

Original Article

Palliative concurrent chemoradiotherapy in locally advanced and metastatic esophageal cancer patients with dysphagia
Fatma Mohamed Farouk Akl, Seham Elsayed-Abd-Alkhalek, Tarek Salah
Annals of Palliative Medicine  
2013;
2
(3)
:118-123
.
Changes in expression of cyclooxygenase-2 in the spinal dorsal horn after intrathecal p38MAPK inhibitor SB203580 on neuropathic pain in rats
Gang Wang, Changsheng Huang, Yichun Wang, Qulian Guo, Haiying Jiang, Jifang Wen
Annals of Palliative Medicine  
2013;
2
(3)
:124-129
.

Review Article

Cryosurgery for colorectal liver metastases
Lizhi Niu, Liang Zhou, Kecheng Xu, Feng Mu
Annals of Palliative Medicine  
2013;
2
(3)
:130-140
.
Traditional Chinese medicine in the treatment of symptoms in patients with advanced cancer
Yang Ling
Annals of Palliative Medicine  
2013;
2
(3)
:141-152
.

News

Welcome to join us in 2013 conferences—Annals of Palliative Medicine
Nancy Q. Zhong
Annals of Palliative Medicine  
2013;
2
(3)
:153-155
.
Highlights in hepatocellular carcinoma
Grace Li
Annals of Palliative Medicine  
2013;
2
(3)
:156-157
.